239 related articles for article (PubMed ID: 36283453)
1. Targeting the epigenome in malignant melanoma: Facts, challenges and therapeutic promises.
Anestopoulos I; Kyriakou S; Tragkola V; Paraskevaidis I; Tzika E; Mitsiogianni M; Deligiorgi MV; Petrakis G; Trafalis DT; Botaitis S; Giatromanolaki A; Koukourakis MI; Franco R; Pappa A; Panayiotidis MI
Pharmacol Ther; 2022 Dec; 240():108301. PubMed ID: 36283453
[TBL] [Abstract][Full Text] [Related]
2. Exploring the role of epigenetic alterations and non-coding RNAs in melanoma pathogenesis and therapeutic strategies.
Rubatto M; Borriello S; Sciamarrelli N; Pala V; Tonella L; Ribero S; Quaglino P
Melanoma Res; 2023 Dec; 33(6):462-474. PubMed ID: 37788101
[TBL] [Abstract][Full Text] [Related]
3. Melanoma epigenetics: novel mechanisms, markers, and medicines.
Lee JJ; Murphy GF; Lian CG
Lab Invest; 2014 Aug; 94(8):822-38. PubMed ID: 24978641
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic Regulation in Melanoma: Facts and Hopes.
Giunta EF; Arrichiello G; Curvietto M; Pappalardo A; Bosso D; Rosanova M; Diana A; Giordano P; Petrillo A; Federico P; Fabozzi T; Parola S; Riccio V; Mucci B; Vanella V; Festino L; Daniele B; Ascierto PA; Ottaviano M; On Behalf Of Scito Youth
Cells; 2021 Aug; 10(8):. PubMed ID: 34440824
[TBL] [Abstract][Full Text] [Related]
5. From chemo-prevention to epigenetic regulation: The role of isothiocyanates in skin cancer prevention.
Mitsiogianni M; Amery T; Franco R; Zoumpourlis V; Pappa A; Panayiotidis MI
Pharmacol Ther; 2018 Oct; 190():187-201. PubMed ID: 29890115
[TBL] [Abstract][Full Text] [Related]
6. Epigenetics of human cutaneous melanoma: setting the stage for new therapeutic strategies.
Sigalotti L; Covre A; Fratta E; Parisi G; Colizzi F; Rizzo A; Danielli R; Nicolay HJ; Coral S; Maio M
J Transl Med; 2010 Jun; 8():56. PubMed ID: 20540720
[TBL] [Abstract][Full Text] [Related]
7. The "ART" of Epigenetics in Melanoma: From histone "Alterations, to Resistance and Therapies".
Strub T; Ballotti R; Bertolotto C
Theranostics; 2020; 10(4):1777-1797. PubMed ID: 32042336
[TBL] [Abstract][Full Text] [Related]
8. Aberrant DNA methylation in malignant melanoma.
Schinke C; Mo Y; Yu Y; Amiri K; Sosman J; Greally J; Verma A
Melanoma Res; 2010 Aug; 20(4):253-65. PubMed ID: 20418788
[TBL] [Abstract][Full Text] [Related]
9. Genetics and epigenetics of cutaneous malignant melanoma: a concert out of tune.
van den Hurk K; Niessen HE; Veeck J; van den Oord JJ; van Steensel MA; Zur Hausen A; van Engeland M; Winnepenninckx VJ
Biochim Biophys Acta; 2012 Aug; 1826(1):89-102. PubMed ID: 22503822
[TBL] [Abstract][Full Text] [Related]
10. Epigenetics of melanoma: implications for immune-based therapies.
Fratta E; Sigalotti L; Covre A; Parisi G; Coral S; Maio M
Immunotherapy; 2013 Oct; 5(10):1103-16. PubMed ID: 24088079
[TBL] [Abstract][Full Text] [Related]
11. Epigenetics and cutaneous neoplasms: from mechanism to therapy.
Gibson F; Hanly A; Fisher R; Wyant WA; Wu M; Collard M; Alani RM
Epigenomics; 2023 Feb; 15(3):167-187. PubMed ID: 37020393
[TBL] [Abstract][Full Text] [Related]
12. Benzyl and phenethyl isothiocyanates as promising epigenetic drug compounds by modulating histone acetylation and methylation marks in malignant melanoma.
Mitsiogianni M; Anestopoulos I; Kyriakou S; Trafalis DT; Franco R; Pappa A; Panayiotidis MI
Invest New Drugs; 2021 Dec; 39(6):1460-1468. PubMed ID: 33963962
[TBL] [Abstract][Full Text] [Related]
13. Cancer stem cells, epigenetics, tumor microenvironment and future therapeutics in cutaneous malignant melanoma: a review.
Kyriakou G; Melachrinou M
Future Oncol; 2020 Jul; 16(21):1549-1567. PubMed ID: 32484008
[TBL] [Abstract][Full Text] [Related]
14. EPIGENETIC CHANGES IN MALIGNANT UVEAL MELANOMA AND POSSIBILITIES OF THEIR THERAPEUTIC TARGETING.
Smolková B; Demková L
Cesk Slov Oftalmol; 2020; 76(2):55-60. PubMed ID: 33126799
[TBL] [Abstract][Full Text] [Related]
15. Epigenetics in human melanoma.
Howell PM; Liu S; Ren S; Behlen C; Fodstad O; Riker AI
Cancer Control; 2009 Jul; 16(3):200-18. PubMed ID: 19556960
[TBL] [Abstract][Full Text] [Related]
16. Epigenetics of human melanoma: promises and challenges.
Besaratinia A; Tommasi S
J Mol Cell Biol; 2014 Oct; 6(5):356-67. PubMed ID: 24895357
[TBL] [Abstract][Full Text] [Related]
17. Epigenetics of malignant melanoma.
Moran B; Silva R; Perry AS; Gallagher WM
Semin Cancer Biol; 2018 Aug; 51():80-88. PubMed ID: 29074395
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic lesions in malignant melanoma.
Schwabe M; Lübbert M
Curr Pharm Biotechnol; 2007 Dec; 8(6):382-7. PubMed ID: 18289047
[TBL] [Abstract][Full Text] [Related]
19. Malignant melanoma: Underlying epigenetic mechanisms.
Sabit H; Kaliyadan F; Menezes RG
Indian J Dermatol Venereol Leprol; 2020; 86(5):475-481. PubMed ID: 32769310
[TBL] [Abstract][Full Text] [Related]
20. Pharmaco-epigenomics: On the Road of Translation Medicine.
López-Camarillo C; Gallardo-Rincón D; Álvarez-Sánchez ME; Marchat LA
Adv Exp Med Biol; 2019; 1168():31-42. PubMed ID: 31713163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
